Adição na publicação
#15.35
10/13/2021
RPI 2649
Application data
Number
112019014524Type
Filing
Publication
PCT
US2018014241 The application was abandoned: examination was not requested within the 36 months following the 01/18/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/13/2021. We update with every new RPI gazette, published weekly.
Applicants
LA JOLLA PHARMACEUTICAL COMPANY
US
Inventors
G. T. (pessoa física)
US
L. C. (pessoa física)
US
Priority claims
US
62/447,710 · 01/18/2017
US
62/454,322 · 02/03/2017
US
62/554,115 · 09/05/2017
Abstract
A presente divulgação refere-se ao uso de hepcidina, mini-hepcidina ou um análogo de hepcidina nos métodos terapêuticos para o tratamento e/ou a prevenção da sobrecarga de ferro adquirida ou outras condições para as quais a redistribuição ou o sequestro do ferro seja útil.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/13/2021
RPI 2649
#11.1.1
07/20/2021
RPI 2637
#11.1
05/04/2021
RPI 2626
#1.3
02/27/2020
RPI 2564
#1.1
07/23/2019
RPI 2533
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.